- Home
- DARE vs DTST Comparison
DARE vs DTST Comparison
Compare DARE & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- DTST
- Stock Information
- Founded
- DARE 2015
- DTST 2001
- Country
- DARE United States
- DTST United States
- Employees
- DARE N/A
- DTST N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- DTST EDP Services
- Sector
- DARE Health Care
- DTST Technology
- Exchange
- DARE Nasdaq
- DTST Nasdaq
- Market Cap
- DARE 27.7M
- DTST 28.2M
- IPO Year
- DARE N/A
- DTST N/A
- Fundamental
- Price
- DARE $2.82
- DTST $3.35
- Analyst Decision
- DARE Strong Buy
- DTST
- Analyst Count
- DARE 3
- DTST 0
- Target Price
- DARE $12.50
- DTST N/A
- AVG Volume (30 Days)
- DARE 33.9K
- DTST 40.6K
- Earning Date
- DARE 08-11-2025
- DTST 08-13-2025
- Dividend Yield
- DARE N/A
- DTST N/A
- EPS Growth
- DARE N/A
- DTST N/A
- EPS
- DARE N/A
- DTST 0.02
- Revenue
- DARE $25,909.00
- DTST $25,219,312.00
- Revenue This Year
- DARE $99,756.91
- DTST $12.57
- Revenue Next Year
- DARE $119.77
- DTST $9.29
- P/E Ratio
- DARE N/A
- DTST $141.00
- Revenue Growth
- DARE N/A
- DTST N/A
- 52 Week Low
- DARE $2.67
- DTST $2.93
- 52 Week High
- DARE $5.76
- DTST $6.95
- Technical
- Relative Strength Index (RSI)
- DARE 39.02
- DTST 37.80
- Support Level
- DARE $2.84
- DTST $3.34
- Resistance Level
- DARE $2.93
- DTST $3.82
- Average True Range (ATR)
- DARE 0.13
- DTST 0.18
- MACD
- DARE -0.03
- DTST -0.05
- Stochastic Oscillator
- DARE 13.21
- DTST 11.11
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.